During the past decade, Holstebro Hospital, Endocrinology dept. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Holstebro Hospital, Endocrinology dept." are "Chronic Kidney Disease" (1 trials), "Diabetic Retinopathy" (1 trials), "Non-diabetic Chronic Kidney Disease" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Holstebro Hospital, Endocrinology dept." in a lesser frequency.

Most popular intervention types in "Holstebro Hospital, Endocrinology dept." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Finerenone (BAY94-8862)" (2 trials), "Placebo" (2 trials), "Empagliflozin" (1 trials) and "Finerenone (Kerendia, BAY94-8862 )" (1 trials). Other intervention names were less common.

The vast majority of trials in "Holstebro Hospital, Endocrinology dept." are 3 trials for "All" genders.

Currently, there are NaN active trials in "Holstebro Hospital, Endocrinology dept.". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Holstebro Hospital, Endocrinology dept., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Holstebro Hospital, Endocrinology dept., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".